TABLE 2

Estimates of Mean Absorbed Radiation Dose in Prostate Cancer Patients and Healthy Volunteers

Target organ123I-MIP-1072 prostate cancer patients (mGy/MBq)123I-MIP-1095 prostate cancer patients (mGy/MBq)123I-MIP-1072 healthy volunteers (mGy/MBq)
Urinary bladder wall*0.0920.0210.120
Salivary glands0.0580.1600.224
Kidneys0.0540.1100.052
Distal colon0.0460.0720.036
Proximal colon0.0400.0660.030
Thyroid0.0380.1000.071
Liver0.0240.0580.021
Spleen0.0230.0470.015
Small intestine0.0210.0330.016
Osteogenic cells0.0190.0300.014
Heart wall0.0160.0340.009
Lungs0.0150.0320.010
Gallbladder wall0.0140.0270.011
Pancreas0.0110.0200.008
Adrenals0.0110.0200.009
Stomach wall0.0090.0150.007
Muscle0.0070.0110.006
Testes0.0070.0080.006
Red marrow0.0070.0110.005
Thymus0.0060.0110.005
Skin0.0040.0070.003
Brain0.0030.0060.002
Total body0.0090.0140.007
Effective dose equivalent (mSv/MBq)0.0250.0370.024
Effective dose (mSv/MBq)0.0220.0320.021
  • * Assumes 4- to 8-h void.

  • Salivary glands represented as 77-g sphere.

  • Thyroid blockade in 4 of 7 prostate cancer patients and not in healthy volunteers.